Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units

C R Hermos1, T J Sandora, L E Williams

  • 1Division of Paediatric Immunology and Infectious Diseases, UMass Memorial Children's Medical Center, Worcester, MA, USA. Christina.hermos@umassmemorial.org

Epidemiology and Infection
|November 30, 2012
PubMed

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains became more common in pediatric intensive care units (ICUs). This shift indicates a growing prevalence of CA-MRSA colonization in critically ill children over time.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatric Critical Care

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasingly implicated in hospital-onset infections.
  • Patient colonization with MRSA is a significant risk factor for developing infections.

Purpose of the Study:

  • To investigate the changing prevalence of CA-MRSA colonization in pediatric intensive care units (ICUs).
  • To characterize the molecular epidemiology and antibiotic susceptibility of MRSA isolates from colonized pediatric patients.

Main Methods:

  • Retrospective analysis of 495 MRSA-colonized pediatric patients across various ICUs from 2001 to 2009.
  • Characterization of MRSA isolates using spa typing, SCCmec typing, and Panton–Valentine leukocidin (PVL) gene detection.
  • Assessment of antibiotic susceptibility patterns over the study period.

Main Results:

  • The overall MRSA colonization rate remained stable at approximately 3.2%.
  • A significant temporal increase was observed in isolates with spa type 1 (up to 36.1%), SCCmec type IV (up to 54.2%), and PVL (up to 28.9%).
  • Increasing susceptibility to clindamycin, gentamicin, tetracycline, and trimethoprim-sulfamethoxazole was noted.

Conclusions:

  • The proportion of CA-MRSA among colonized pediatric patients in ICUs significantly increased between 2001 and 2009.
  • This trend highlights a shift towards CA-MRSA strains in pediatric intensive care settings.
  • Evolving antibiotic susceptibility patterns warrant ongoing surveillance.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...